BS PHARM KOREA Completes a Successful Exhibition at AMWC KOREA 2026
BS PHARM KOREA successfully concluded its participation in AMWC KOREA 2026, held on June 19–20 at the Grand InterContinental Seoul Parnas.
As the first AMWC event held in Korea, the congress brought together medical aesthetic professionals, industry experts, and business partners from Korea and international markets.
Throughout the two-day event, the BS PHARM KOREA booth welcomed visitors from the United States, Europe, Latin America, the CIS region, and other global markets. The strong international interest provided a valuable opportunity to introduce our aesthetic product portfolio, exchange market insights, and explore new possibilities for global collaboration.
Global Interest in Korean Medical Aesthetic Solutions
Korea continues to attract attention as a major center of innovation within the global medical aesthetics industry.
At AMWC KOREA 2026, visitors showed significant interest in Korean skin boosters, ingredient-driven aesthetic solutions, and products developed to support modern approaches to skin quality management.
At the BS PHARM KOREA booth, our team met with distributors, clinic representatives, medical professionals, and industry partners from a wide range of regions.
These conversations allowed us to better understand the needs of individual markets while presenting solutions developed around product quality, differentiated ingredients, and professional aesthetic applications.
Product Highlight: INHILO+ Dual HA Skin Booster
One of the key products presented at AMWC KOREA 2026 was INHILO, an MFDS-approved HA Skin Booster developed with a balanced Dual HA formulation.
INHILO combines high- and low-molecular-weight hyaluronic acid in a single formulation. This integrated approach is designed to support hydration and overall skin quality while responding to the growing market interest in HA-based skin booster solutions.
The product attracted attention from global visitors seeking Korean aesthetic products with differentiated formulation strategies and domestic regulatory recognition.
Key Features of INHILO+
- – MFDS-approved HA Skin Booster
- – High- and low-molecular-weight hyaluronic acid
- – Balanced Dual HA formulation
- – Part of BS PHARM KOREA’s expanding skin booster portfolio
Product Highlight: NA:DRN with NAD+ and PDRN
NADRN was another featured solution that received strong interest from visitors at the exhibition.
The formulation combines NAD+ and PDRN, two ingredients associated with emerging approaches to skin vitality, tissue-supportive care, and ingredient-focused aesthetic solutions.
NAD+ has gained attention in the global longevity and cellular energy sectors, while PDRN is widely recognized within the Korean medical aesthetics market. By bringing these ingredients together, NA reflects BS PHARM KOREA’s continued focus on developing differentiated products aligned with evolving global trends.
Features of NA:DRN
- – Formulated with NAD+ and PDRN
- – Ingredient-driven skin booster concept
- – Aligned with growing interest in longevity and skin vitality
- – Designed as part of a broader skin quality management portfolio
Sharing a Broader Portfolio of Aesthetic Solutions
Beyond INHILO and NA, BS PHARM KOREA introduced visitors to a broader portfolio of medical aesthetic and beauty solutions.
Our portfolio continues to expand across multiple product categories and ingredient platforms, including:
- – Hyaluronic acid-based skin boosters and dermal fillers
- – PN- and PDRN-based solutions
- – Exosome-based products
- – Peptide formulations
- – NAD+-focused aesthetic solutions
- – PLLA and collagen-supportive products
- – Professional skincare and post-procedure care products
By developing solutions across diverse aesthetic categories, BS PHARM KOREA aims to respond to different market needs and provide business partners with a wider range of product opportunities.
Building New Connections Across Global Markets
Participation in AMWC KOREA 2026 provided BS PHARM KOREA with an important opportunity to strengthen its international network.
Discussions with visitors from North America, Europe, Latin America, the CIS region, and other markets covered a variety of topics, including product distribution, regulatory requirements, local market demand, and potential business collaboration.
These interactions reinforced the growing global interest in Korean medical aesthetic products and highlighted the importance of developing products that combine market relevance, differentiated ingredients, and reliable business support.
Advancing Global Partnerships After AMWC KOREA 2026
BS PHARM KOREA would like to thank everyone who visited our booth and shared their interest in our products during AMWC KOREA 2026.
The exhibition was more than an opportunity to present individual products. It was a meaningful platform for exchanging ideas, identifying new market opportunities, and building relationships with aesthetic professionals and business partners worldwide.
Following the event, BS PHARM KOREA will continue to develop innovative aesthetic solutions and expand strategic partnerships across key global markets.
Learn More About BS PHARM KOREA
Explore our range of skin boosters, dermal fillers, ingredient-focused aesthetic solutions, and professional beauty products.
For product information, distribution inquiries, or partnership opportunities, please contact the BS PHARM KOREA team.
Frequently Asked Questions
What is AMWC KOREA?
AMWC KOREA is an international congress and exhibition for aesthetic and anti-aging medicine professionals. The 2026 event marked the first AMWC edition held in Korea.
Which products did BS PHARM KOREA feature at AMWC KOREA 2026?
The main product highlights were INHILO, an MFDS-approved Dual HA Skin Booster, and NA, a formulation featuring NAD+ and PDRN. BS PHARM KOREA also introduced its wider portfolio of aesthetic and beauty solutions.
What is INHILO?
INHILO is an HA Skin Booster developed with high- and low-molecular-weight hyaluronic acid in a balanced Dual HA formulation.
What is NA:DRN?
NA is an ingredient-focused aesthetic solution formulated with NAD+ and PDRN.
Does BS PHARM KOREA work with international distributors?
BS PHARM KOREA welcomes inquiries from distributors, clinics, medical aesthetic professionals, and business partners across global markets.
